John C. McKew
2022
In 2022, John C. McKew earned a total compensation of $1.1M as President and Chief Scientific Officer at NewLink Genetics, a 24% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $374,969 |
---|---|
Option Awards | $99,685 |
Salary | $535,096 |
Stock Awards | $15,030 |
Other | $33,398 |
Total | $1,058,178 |
McKew received $535.1K in salary, accounting for 51% of the total pay in 2022.
McKew also received $375K in non-equity incentive plan, $99.7K in option awards, $15K in stock awards and $33.4K in other compensation.
Rankings
In 2022, John C. McKew's compensation ranked 2,908th out of 5,753 executives tracked by ExecPay. In other words, McKew earned more than 49.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,908 | 50th |
Manufacturing | 1,629 | 48th |
Chemicals And Allied Products | 760 | 46th |
Drugs | 709 | 46th |
Pharmaceutical Preparations | 513 | 47th |
McKew's colleagues
We found two more compensation records of executives who worked with John C. McKew at NewLink Genetics in 2022.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021
NewLink Genetics Former Chief Executive & Scientific Officer Charles Link's 2019 pay falls 38% to $1.7M
June 23, 2020